Morgan Stanley analyst Tejas Savant lowered the firm’s price target on Charles River (CRL) to $184 from $220 and keeps an Equal Weight rating ...
Analysts have been eager to weigh in on the Healthcare sector with new ratings on TransMedics Group (TMDX – Research Report), Amgen (AMGN – ...
Three-time Cy Young Award winner Max Scherzer will look to rebound in 2025 after reportedly agreeing to a new one-year, $15.5 million deal with the ...